Tag Archives: Shares

Pressemitteilungen

SES Mining Co. Rejects Takeover Attempt due to Gross Undervaluation of its Current and Potential Assets.

Junior gold developer SES Mining Co has rejected an unsolicited takeover offer from a consortium comprising of multiple medium and senior miners in the region.

The China-based company – which operates the Yuangguang gold project in South-Western Tibet’s Sichuan region – received a non-binding and incomplete letter of intent from the bidding partners outlining a proposal to acquire 7.9% of SES Mining’s issued share capital.

After discussions with its advisors and following consultation with some of its largest shareholders, SES has rejected the bid on the basis that it undervalues the company and its assets.

The company has advised the consortium it is open to considering an alternative proposal.

In the meantime, SES Mining’s board of directors have committed to introducing a formal process to seek expressions of interest from other potential buyers of the company and its projects, or parties wishing to form a joint venture to develop the Yuangguang project under its current structure.

“The board is focusing on getting the company’s efficiency and extraction rates into an optimum state before running a proper process in the coming months to revisit past failed transactions and to seek other potential suitors.” the company said.

Yuangguang mine exploration update: June 2019

The company said exploration, which kicked off during April 2017 at the wholly-owned project, will focus on extending the mineral resource past the current 101 million ounces of contained gold.

Activities will also aim to generate the next round of laser drilling targets at Yuangguang.

In August 2018, SES secured a 120-room accommodation village and related mining infrastructure for the Yuangguang development for US$1.2 million.

At the time, SES Mining’s founding chairman Wang Jianlin said the continued investor support represented a strong vote of confidence in the company’s strategy to become a substantial new mid-tier gold producer through the successful development of Yuangguang.

SES Mining are based at No. 8, Jianguomenbei Avenue, Dongcheng District, Beijing, China 100005. Call us on +86 10 58 11 18 45 or email us at info@sesminingco.com.

Media Contact
SES Mining Co
Mr Wang Jianlin
wangjianling@sesminingco.com
+86 10 58 11 18 45

Pressemitteilungen

Neutrino Energy Group – Mit großen Schritten in Richtung IPO

Neutrino Energy Group, die Unternehmensgruppe, die in Ihrem Namen bereits darauf hinweist, wie die Energiewende in der Welt zu schaffen ist, indem sie wie bereits vielfach berichtet den Partikelstrom aus Milliarden von Neutrinos und anderer Bestandteile der nichtsichtbaren kosmischen und solaren Strahlenspektrendazu nutzt, um daraus elektrische Energie zu gewinnen, setzt den Prozess fort an die US amerikanische Börse zu gehen.

Kosmische Energie, die nichtsichtbaren Strahlenspektren, stehen 24 Stunden und 7 Tage die Woche, bei Tag und eben auch bei Nacht, im Freien oder in einem Gebäude, also gleich wo zur Verfügung und sorgen dafür, dass die Menschheit in Zukunft unabhängig von der Verbrennung fossiler Brennstoffe sein wird.

Diese Möglichkeiten wurden nach langen kontroversen Auseinandersetzungen in den letzten Jahren nun wissenschaftlich u. a. durch den Nobelpreis in Physik und viele, sogar notariell beaufsichtigte Experimente bestätigt.

Das unternehmerische Ziel für die Zukunft ist „Neutrino Inside“, d. h. technische Geräte durch die Industrie in Lizenz fertigen zu lassen, welche völlig unabhängig vom derzeitigen Stromnetz funktionieren;drahtlose Energieübertragung, Energie aus der Umgebung ernten, die Zukunft kennt weder Stromkabel noch Steckdose.

Eine solche bedeutende Veränderung beginnt mit der Aufklärung der Bevölkerung; denn die meisten Menschen glauben heute immer noch, dass das heutige System aus zentraler Stromversorgung und Netzverteilung alternativlos sei. Darunter versteht man, dass in großen Kraftwerken eine ungeheure Menge Energie zentral erzeugt wird, die dann über tausende Kilometer Stromleitungen unter enormen Verlusten und mit hohen Kosten zu den Verbrauchern gelangt (Strom aus der Steckdose, wie bereits vor 100 Jahren).

Neuartige Technologien und Möglichkeiten zum Schutz von Klima und Umwelt müssen heute Vorrang bekommen. „Neutrino Power, diese Form der Energiewandlung reicht für die umweltfreundliche Abdeckung des Weltenergiebedarfs, das Thema ist physikalisch durch“, so Prof. Dr. Konstantin Meyl.

Der weltweite „Informations roll out“ kostet enorm viel Geld und es ist extrem wichtig unabhängig zu bleiben, dies ist ein wesentlicher Grund des geplanten IPO, denn viele segensreiche Erfindungen in den letzten Jahren oder Jahrzehnten wurden aufgekauft und sind auf Nimmerwiedersehen in den Schubladen etablierter Systeme gut eingelagert oder ganz verschwunden.Besonders anfällig sind hierbei wissenschaftliche Erkenntnisse und Erfindungen aus den Bereichen der Energie- und Medizienforschung.

Die Neutrino Energy Group hat daher bereits im Jahr 2017 mit dem „Informations roll out“ und den notwendigen Vorbereitungen zum IPO begonnen. Das Börsenumfeld hatte sich ab Beginn des Jahres 2018 so eingetrübt, dass es die richtige Entscheidung war, noch etwas abzuwarten. Die Neutrino Energy Group wird sicherstellen, dass sowohl ein listing in Deutschland wie auch in den USA zu den gleichen Bedingungen stattfindet.

Bei der Auswahl der Partner zeigt sich schon jetzt das ungeheure Potenzial. Alle angesprochenen Investmenthäuser, Analysten oder Experten haben von einem der bedeutendsten Börsengänge überhaupt gesprochen, nicht nur wegen der einmaligen Technologie, sondern auch wegen des geplanten Emissionsvolumens und den von ihnen hochgerechneten Marktwerten (bereits am ersten Börsentag aber insbesondere in den kommenden Jahren). Die ersten Schätzungen bewegen sich in Werten, die seinerzeit an den Ausgabepreis der Facebook Aktie erinnern, etwas über 30 USD die Aktie.

Prof. Dr. M. Geske, Wirtschaftswissenschaftler und Experte für Börsengänge und insbesondere Experte auf den US – Märkten dazu:“Der 1. Kurs dürfte konservativ zwischen 30 – 40 US$ liegen und bei dem nachhaltigen Marktpotenzial, ist mit einem 10-fachen davon bereits innerhalb von 24 – 36 Monaten zu rechnen. Amerikanische Aktien werden im Gegensatz zu deutschen und europäischen Werten nicht rückwärtsgewandt, sondern immer zukunftsorientiert bewertet. Das macht viel mehr Sinn, denn was nützt die beste Bilanz aus den vergangenen Jahren. Die Erfolge der Vergangenheit sind heutzutage kein Garant mehr für ein Erfolg von morgen. Nur der, dessen Geschäftsmodell auf die Produkte in der Zukunft setzt, wird in der Zukunft auch Erfolg haben und dessen Aktien sind begehrt und wertvoll.“

Wer begleitet solche Prozesse? Dies sind u. a. Häuser wie JP Morgan, Goldman Sachs, Morgan Stanley, Bank of America – Merrill Lynch, Barclays, CS, DB usw.

„Wir werden mit den Besten der Besten arbeiten, mit denen, die ihr Geschäft verstehen, den Markt kennen, ihn analysieren können und bereits vielfach erfolgreich einen solchen Prozess begleitet oder durchgeführt haben“, so Holger Thorsten Schubart, CEO der Neutrino Energy Group.“Wir werden mit viel Ruhe den optimalen Zeitpunkt mit den Partnern abstimmen. Börsentechnisch gibt es klare Wege, die wir bereits konkretisiert haben. Dabei prüfen wir, welcher am besten zu unserem Unternehmen und auch am besten für unsere Aktionäre sein wird. Dies kann z. B. auch eine Fusion oder Verschmelzung mit einem bereits gelisteten Unternehmen, um den Prozess zu beschleunigen, sein. International sind wir bereits mit einigen Big Playern im Gespräch, ein börsennotiertes deutsches Großunternehmen arbeitet bereits an einem ersten Prototyp. Aufgrund umfangreicher Geheimhaltungsvereinbarungen werde ich hier keine weiteren Details veröffentlichten.Bedenken Sie, dass unsere neue Technologie die aktuelle Produktion eines solchen Unternehmens vollständig in Frage stellt. Ein Unternehmen ist insbesondere auch darauf angewiesen, erst einmal das, was in den letzten Jahren entwickelt wurde, auch zu verkaufen. Milliarden an Entwicklungskosten für die aktuelle Produktion müssen sich erst einmal amortisieren.Das werden viele Unternehmen nicht schaffen. Da in der heutigen extrem dynamischen Zeit technisch und technologische Neuerungen und Verbesserungen sehr kurzfristig auf den Markt kommen, kann es bei Markteinführung durchaus sein, dass die Produkte dann bereits veraltet sind.Ich persönlich würde dem Verbraucher daher raten, nachzufragen und nachzuhaken, ob kommende Geräte schon mit der neuesten Technology “ Neutrino inside“ ausgestattet sind. Die Zukunft hält viele spannende Innovationen für uns bereit“, ergänzt Holger Thorsten Schubart.

Ein Investment in Neutrino ist vor allem der richtige Schritt für ein Investment in die Zukunft unserer Kinder und einer sauberen Umwelt. Mit der Börsenlistung und der Vergabe der ISIN-Nummer wird die Aktie in Kürze für jedermann zu erwerben sein; zurzeit ist diese nur im Private Placement für einen kleinen Kreis ausgesuchter Aktionäre verfügbar.

„Ein Zukunftswert, den man in seinem Depot haben sollte, denn die Entwicklung und das damit verbundene zukünftige Potential ist gerade mittel- und langfristig mehr als nur vielversprechend“, ergänzt Prof. Dr. M. Geske.

NEUTRINO Deutschland GmbH ist ein Deutsch-US-Amerikanisches Forschungs-und Entwicklungsunternehmen unter Führung des Mathematikers Holger Thorsten Schubart. Dieses, mit Hauptsitz in Berlin, steht in Kooperation mit einem weltweiten Team an Wissenschaftlern und verschiedensten internationalen Forschungsstätten, welche sich mit der Anwendungsforschung, der Wandlung nichtsichtbarer Strahlenspektren der Sonne, unter anderem den Neutrinos (hochenergetischen Teilchen, die unaufhörlich die Erde erreichen) in elektrischen Strom beschäftigt.

Besonderer Schwerpunkt stellt dabei die Zusammenarbeit mit Universitäten und Hochschulen im Bereich der Grundlagenforschung dar sowie die Bildung eines internationalen Forschungsnetzwerkes für alternative Energietechnologien.

Das wirtschaftliche Ziel der NEUTRINO ENERGY Gruppe ist, aus den Erkenntnissen der Grundlagen-forschungen, technische Anwendungslösungen für den täglichen Gebrauch zu entwickeln und diese zu vermarkten.

Die US-Amerikanische Muttergesellschaft NEUTRINO INC., gegründet 2008, plant in den nächsten Jahren den Börsengang an der US Technologiebörse NASDAQ. Der Werbeslogan des Unternehmens lautet: „NEUTRINO ENERGY, THE ENERGY OF THE FUTURE.“

Firmenkontakt
Neutrino Deutschland GmbH
Holger Thorsten Schubart
Unter den Linden 21-23
10117 Berlin
+49 30 20924013
office@neutrino-energy.com
http://www.neutrino-energy.com

Pressekontakt
Pressekontakt Heiko Schulze
Heiko Schulze
Haus der Bundespressekonferenz 0413
10117 Berlin
+49 30 726262700
+49 30 726262701
heiko.schulze.bpk@gmail.com
http://www.neutrino-energy.com

Die Bildrechte liegen bei dem Verfasser der Mitteilung.

Pressemitteilungen

A Market for Omega-3 Products in the Form of Application, Geography and its Inclusivity in Different Food Items

Omega 3 fatty acids belongs to essential polysaturated fatty acids category. Omega 3 fatty acids are extensively found in flaxseed oil, canola oil, halibut, salmon, herring, trout, cod, and spinach, clams, shrimp, and chia seeds, among others. There are three different types of omega 3 fatty acids such as α-linolenic acid (ALA) found in plant sources, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are extensively found in fish in high concentrations. Due to its great health benefits such as improving eye health, controlling blood pressure and cholesterol, among others, they are filled in the market and available as oral supplements under various brand names.

Factors such as increase in the prevalence of cardiovascular diseases is the key factor enhancing the growth of the omega 3 ingredients market. Rising health consciousness among the people is the attributing the market growth. Its application in various functional and food supplements is anticipating the growth of the omega 3 ingredients market. Increase in research and development activities are adding scope for the manufacturers in expansion. However, the stringent government regulations are likely to hamper the market growth of the omega 3 ingredients.

The global market of Omega 3 ingredients market is categorized as follows-

1. Application

· Pharmaceuticals

· Pet and Animal Feed

· Supplements and Functional Foods

· Infant formula

· Others

And on basis of geographical regions, the global omega 3 ingredients market is divided into five main regions- North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America omega 3 ingredients market is the dominant market when compared with that of the other regional markets. Owing to the presence of various industries such as pharmaceutical industries and food industries, the growth of the omega 3 ingredients is found to have a significant growth in this region. The next in line is Europe region in the global omega 3 ingredients market. The Asia Pacific omega 3 ingredients market is expected to grow exponentially in the near future due to the presence of emerging economies such as China, Japan, and India.

Some of the players in the global omega 3 ingredients market include Simris Alg (Sweden), Algisys (U.S), Polaris (U.S), Terravia (Solazyme) (U.S), Bioceuticals (U.S), DSM Nutritional Products (Netherlands), Bioprocess Algae, LLC (U.S), Neptune Wellness Solutions (Canada), Source-Omega (U.S). Some of the market developments include Nordic Naturals introducing five new children’s products at natural products in 2018. The new products offer concentrated, triglyceride-form omega-3 fish oil in age-appropriate formulations for cognition, learning and attention, mood health, and more, plus a kid-friendly, fast-melt probiotic powder.

For More Information: https://www.precisionbusinessinsights.com/market-reports/omega-3-ingredients-market/

Aktuelle Nachrichten Gesundheit/Medizin Marketing/Werbung Mode/Lifestyle

Global Phototherapy Equipment Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Phototherapy Equipment Market: By Device Type (Fluorescent Lamps, Compact Fluorescent Lamps, Fiberoptic Phototherapy Equipment, LED Phototherapy Equipment, and Conventional Phototherapy Equipment), By Application (Neonatal Jaundice and Skin Diseases), By End User (Hospitals, Clinics, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global phototherapy equipment market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

Market Outline: Phototherapy Equipment Market

Phototherapy or light therapy involves exposing the skin to ultraviolet light on a regular basis and under medical supervision. The UV part of the radiation emitted by the sun that is used in phototherapy, especially the ultraviolet B (UVB) and ultraviolet A (UVA) wavelengths. Using phototherapy, exposure of specific wavelengths of light using polychromatic polarized light, fluorescent lamps, and lasers is used for the treatment.

 

Market Dynamics: Phototherapy Equipment Market

Increase in the prevalence of neonatal jaundice and growing number of the preterm birth are the key factors attributed for the growth of the phototherapy equipment market. According to the National Center for Biotechnology Information (NCBI), around 13 million babies are affected with jaundice all across the globe. The increasing incidence of the psoriasis is aiding the growth of the phototherapy equipment market. According to the International Federation of Psoriasis Associations (IFPA), around 150,000 new cases are reported in the U.S every year and 3% of people are affected by some form of psoriasis around the world. The treatment of these skin disorders requires phototherapy, which is expected to boost the growth of the market. However, the high cost of the equipment may hinder the growth of the phototherapy equipment market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Phototherapy Equipment Market

Phototherapy equipment market is segmented based on the device type, application, and distribution channel

Based on the device type, the market is segmented into the following:

  • Fluorescent Lamps
  • Compact Fluorescent Lamps
  • Fiberoptic Phototherapy Equipment
  • LED Phototherapy Equipment
  • Conventional Phototherapy Equipment

Based on the application, the market is segmented into the following:

  • Neonatal Jaundice
  • Skin Diseases
    • Psoriasis
    • Eczema
    • Other skin diseases
  • Others

Based on the distribution channel, the market is segmented into the following:

  • Hospitals
  • Clinics
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Phototherapy Equipment Market

Geographically, global phototherapy equipment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America phototherapy equipment market to keep top spot in the global phototherapy equipment market. The rising awareness among the people regarding the modern treatment procedures for treating skin-related disorders is enhancing the growth of the phototherapy equipment market. For instance, according to the American Academy of Dermatology acne is the most common skin condition in the U.S., affecting around 50 million people in the country each year. Europe and Asia Pacific phototherapy equipment market is expected to grow exponentially over the forecast period.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Phototherapy Equipment Market

Some of the players in the global phototherapy equipment market include:

  • Atom Medical Corporation (Japan)
  • National Biological Corp. (U.S.)
  • Solarc Systems Inc. (Canada)
  • GE Healthcare (U.K.)
  • Philips Lighting Holding B.V. (Netherlands
  • Natus Medical Incorporated (U.S.)
  • Phoenix Medical Systems Pvt. Ltd. (India)
  • Herbert Waldmann GmbH & Co. KG (Germany)

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/phototherapy-equipment-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

Aktuelle Nachrichten Finanzen/Wirtschaft Gesundheit/Medizin Internationales Marketing/Werbung Pressemitteilungen

Global Thrombocytopenia Treatment Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Thrombocytopenia Treatment Market: By Drug Class (Lysosomal Enzyme, Platelet Stimulating Agents, and Glucocorticoids), By Disease Indication (Leukemia, Hemolytic Uremic Syndrome, Immune Thrombocytopenia, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global thrombocytopenia treatment market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Thrombocytopenia Treatment Market

Thrombocytopenia is the condition where in which the patient has a low platelet count. The root cause for the thrombocytopenia are the platelet splenic sequestration, inefficiency in the production of the platelets and the destruction of the platelets. Thrombocytopenia is either inherited or acquired. It usually occurs owing to various disorders such as leukemia and immune system related conditions. This is commonly found in both adults and children. In thrombocytopenia condition show very less symptoms and is mild. In some cases, the count of the platelets is so low that it causes dangerous internal bleeding, as the patient affected with the thrombocytopenia leads to delayed blood clotting or sometimes no blood clotting.

 

Market Dynamics: Thrombocytopenia Treatment Market

Increase in the prevalence of thrombocytopenia all across the globe and rising count of the chronic hepatitis C cases, which causes the risk of thrombocytopenia are likely to drive the growth of the market. The growing government support by financial aids to the patients in developing and under developed countries expected to drive the market revenue growth over forecast period. However, the stringent government regulations for approvals of newer treatments and increasing introduction of the generic drugs may hinder the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Thrombocytopenia Treatment Market

Thrombocytopenia treatment market is segmented based on the drug class, disease indication, and distribution channel

 

Based on the drug class, the market is segmented into the following:

  • Lysosomal Enzyme
  • Platelet Stimulating Agent
  • Glucocorticoids

Based on the disease indication, the market is segmented into the following:

  • Leukemia
  • Hemolytic Uremic Syndrome
  • Immune Thrombocytopenia
  • Others

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Thrombocytopenia Treatment Market

Geographically, global thrombocytopenia treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America thrombocytopenia treatment market is growing due to increase in the prevalence of thrombocytopenia. The deep-rooted healthcare infrastructure is also anticipated to drive the growth of the market in the region. The awareness among the patient population regarding the new treatment methods is likely to enhance the growth of the market in the region. The adoption of the new treatment procedures by the patient pool is boosting the growth of the thrombocytopenia treatment market in the region.

 

Competition Assessment: Thrombocytopenia Treatment Market

Some of the players in the global thrombocytopenia treatment market include:

  • Merck & Co., Inc. (U.S)
  • Bristol-Myers Squibb Company (U.S)
  • ViroMed Co., Ltd (South Korea)
  • Rigel Pharmaceuticals, Inc. (U.S)
  • Shionogi & Co., Ltd. (Japan)
  • Cellerant Therapeutics, Inc. (U.S)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Thrombocytopenia Treatment Market

  • In February 2018, Shionogi & Co., Ltd announced that the New Drug Application (NDA) for lusutrombopag (S-888711), an investigational, once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist, has been accepted for filing and has been granted Priority Review by the U.S. Food & Drug Administration (FDA)

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/thrombocytopenia-treatment-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

Aktuelle Nachrichten Gesundheit/Medizin Internationales Marketing/Werbung Medien/Entertainment Pressemitteilungen Wissenschaft/Forschung

Tissue Engineered Collagen Biomaterials Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Tissue Engineered Collagen Biomaterials Market: By Source (Marine, Bovine, Chicken, Porcine, and Others), By Application (Wound Care, Orthopedic, and Others), By Distribution Channel (Hospitals, Orthopedic Clinics, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global tissue Engineered collagen biomaterials market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Tissue Engineered Collagen Biomaterials Market

Collagen is the class of protein that is widely distributed in the human body. The collagen-based biomaterials has been used intensively in the tissue engineering applications. There are various methods such as multiple-cross linking and several combinations of biopolymers are being investigated, which further helps in improving the tissue function.

Increase in the use of collagen as the bone substitutes is the key factor attributed for the growth of the market. The growing initial investments in the research and development activities and rising use of the collagen in the wound healing process is enhancing the growth of the market. However, stringent government regulations are likely to hamper the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/tissue-engineered-collagen-biomaterials-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Tissue Engineered Collagen Biomaterials Market

Tissue Engineered collagen biomaterials market is segmented based on the source, applications, and distribution channel

Based on the source, the market is segmented into the following:

  • Marine
  • Bovine
  • Chicken
  • Porcine
  • Others

Based on the application, the market is segmented into the following:

  • Wound Care
  • Orthopedic
  • Others

Based on the distribution channel, the market is segmented into the following:

  • Hospitals
  • Orthopedic Clinics
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/tissue-engineered-collagen-biomaterials-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Tissue Engineered Collagen Biomaterials Market

Geographically, global tissue engineered collagen biomaterials market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America tissue Engineered collagen biomaterials market holds dominant share when compared with that of the other regional markets. The soaring use of the collagen in numerous orthopedic applications is anticipated to drive the growth of the market in the region. The European region and the Asia Pacific follow the suit. The Asia Pacific is expected to show significant growth over the forecast period owing to its burgeoning ageing population. The increasing prevalence of chronic diseases is another factor attributed for the growth of the market in the region.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/tissue-engineered-collagen-biomaterials-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Tissue Engineered Collagen Biomaterials Market

Some of the players in the global tissue Engineered collagen biomaterials market include:

  • Medtronic (U.S)
  • Collagen Solutions Plc (UK)
  • Kyeron B.V (The Netherlands)
  • Collagen Matrix Inc (U.S)
  • Fraunhofer-Gesellschaft (Germany)
  • Maxigen Biotech Inc (Taiwan)
  • Advanced BioMatrix Inc (U.S)

 

Notable Market Developments: Tissue Engineered Collagen Biomaterials Market

  • In July 2017, Collagen Solutions plc has announced its first patient enrolment in ChondroMimetic long-term clinical study.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/tissue-engineered-collagen-biomaterials-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

Aktuelle Nachrichten Finanzen/Wirtschaft Gesundheit/Medizin Internationales Marketing/Werbung

Global Uveal Melanoma Therapeutics Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Uveal Melanoma Therapeutics Market: By Disease Type (Choroidal Melanomas, Iris Melanomas, and Ciliary Body Melanomas), By Treatment Type (Chemotherapy, Immunotherapy, and Targeted Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global uveal melanoma therapeutics market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Uveal Melanoma Therapeutics Market

Uveal melanoma is a disease in which malignant (cancer) cells form in the tissues of the eye. The tumors arise from the melanocytes that reside within the uvea giving color to the eye. Uveal melanoma begins between the three layers of the wall of the eye. The first layer (outer layer) includes sclera and the cornea at the front of the eye. The inner layer has a retina, that senses light and send images. The middle layer is the layer in which the melanoma forms. This layer is called as uvea.

Increase in the prevalence of uveal melanoma is driving the growth of the market. The rising awareness among the people regarding the disease among healthcare fraternity is anticipated to drive the growth of the uveal melanoma therapeutics market. However, the higher cost of the therapy and reimbursement policies are may constrain the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Uveal Melanoma Therapeutics Market

Uveal melanoma therapeutics market is segmented based on the disease type, treatment type, and distribution channel.

Based on the disease type, the market is segmented into the following:

  • Choroidal Melanomas
    • Small Melanomas
    • Medium-sized Melanomas
    • Large Melanomas
  • Iris melanomas
  • Ciliary Body Melanomas

Based on the treatment type, the market is segmented into the following:

  • Chemotherapy
    • Methotrexate
    • Others
  • Immunotherapy Drugs
    • Pembrolizumab
    • Ipilimumab
    • Others
  • Targeted Drugs

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Uveal Melanoma Therapeutics Market

Geographically, global uveal melanoma therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America uveal melanoma therapeutics market is driven by increase in the prevalence of the eye related disorders. The growing patient population with uveal melanoma disorder expected fuel the market growth in the region. According to the American Cancer Society, about nine of 10 melanomas of the eye develop in the choroid. It also states that 2,730 new cases were detected in 2014 of uveal melanoma in the U.S.

 

Competition Assessment: Uveal Melanoma Therapeutics Market

Some of the players in the global uveal melanoma therapeutics market include:

  • Eli Lilly & Co. (U.S)
  • Novartis AG (Switzerland)
  • AstraZeneca plc (UK)
  • Pfizer, Inc. (U.S)
  • Merck (U.S)
  • Roche (Switzerland)
  • Amgen (U.S)
  • Bayer (Germany)
  • Spectrum Pharmaceuticals, Inc. (U.S)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Uveal Melanoma Therapeutics Market

  • Bristol-Myers Squibb and National Cancer Institute (NCI) completed the phase II study of Nivolumab in combination with Ipilimumab for Uveal Melanoma

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/uveal-melanoma-therapeutics-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

Aktuelle Nachrichten Gesundheit/Medizin Internationales Marketing/Werbung Pressemitteilungen

Global Vagus Nerve Stimulation (VNS) Devices Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Vague Nerve Stimulation (VNS) Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Vague Nerve Stimulation (VNS) Devices Market: By Product Type ( Implantable VNS Devices and External VNS Devices ), By Application ( Depression, Epilepsy, and Migraine ), By End User ( Hospitals, Ambulatory Surgical Centers (ASCS), and Others) , and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Vague Nerve Stimulation (VNS) devices market valued at US $ XX Mn in 2017 and is expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Vagus Nerve Stimulation (VNS) Devices Market

Vagus nerve stimulation process involves implantation of a device that stimulates the vagus nerve with electrical impulses. The vagus nerves are a pair of nerves that start in the brain and run through the body. This is a nervous play in the conversation between the brain and the body. The vagus nerve stimulation is most often used to treat epilepsy. Vagus nerve stimulation devices are designed to prevent seizures by sending regular, mild pulses of electrical energy to the brain via the vagus nerve. Vagus nerve stimulation device is sometimes referred to as a „pacemaker for the brain.“ The device is placed under the skin on the chest and a wire runs from it to the vagus nerve in the neck.

 

Market Dynamics: Vagus Nerve Stimulation (VNS) Devices Market

According to the WHO, 4.5% -11% of all illnesses. The increasing prevalence of neurological disorders such as migraine and epilepsy among all age groups is expected to drive the market revenue growth. The increasing R & D activities, favorable reimbursement policies are expected to fuel the growth of the Vagus Nerve Stimulation (VNS) devices market. However, the higher treatment costs may be the growth of the market. According to the Epilepsy Foundation, VNS therapy currently costs approximately $ 30,000.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Vagus Nerve Stimulation (VNS) Devices Market

Vagus Nerve Stimulation (VNS) devices market is segmented based on the product type, by application, and end user

Based on the product type, the market is segmented into the following:

  • Implantable VNS Devices
  • External VNS Devices

Based on the application, the market is segmented into the following:

  • Depression
  • Epilepsy
  • Migraine

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Vagus Nerve Stimulation (VNS) Devices Market

Geographically, global vagus nerve stimulation (VNS) devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America Vagus nerve stimulation (VNS) devices market is the fastest growing region. The increasing prevalence of the neurological disorders and the rise in the adoption of the VNS devices for the treatment of various neurological disorders expected to add fuel the market revenue growth. European market stands next to the North America market. Asia Pacific is the region expected to offer lucrative opportunities owing to rapid development in healthcare technology with a huge patient pool.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Vagus Nerve Stimulation (VNS) Devices Market

Some of the players in the global vagus nerve stimulation (VNS) devices market include:

  • LivaNova PLC (UK)
  • EnteroMedics Inc. (US)
  • ElectroCore Medical LLC (US)
  • Boston Scientific Corporation (US)
  • Cyberonics, Inc. (US)
  • NeuroMetrix, Inc.(US)
  • ImThera Medical (US)
  • Inspire Medical Systems, Inc.(US)

 

Notable Market Developments: Vagus Nerve Stimulation (VNS) Devices Market

  • In October 2017, LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, received U.S. Food and Drug Administration (“FDA”) approvals for its latest Vagus Nerve Stimulation Therapy (“VNS Therapy”) System, which consists of the SenTiv implantable generator and the next-generation VNS Therapy Programming System for the treatment of patients with drug-resistant epilepsy.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/vagus-nerve-stimulation-vns-devices-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firms, which follows a holistic approach to solve the needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and making better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): 1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

Aktuelle Nachrichten Gesundheit/Medizin Internationales Marketing/Werbung Pressemitteilungen

Global Vitrectomy Machines Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Vitrectomy Machines Market: By Product Type (Vitrectomy Machines, Vitrectomy Packs, Microscopic Illumination Equipment, Surgical Instruments, and Others), By Application (Retinal Detachment, Diabetic Retinopathy, Trauma, Macular Surgery, Pediatric Retinal Disorders, and Others), By End Users (Hospitals, Eye Clinics, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global vitrectomy machines was valued at US $ XX Mn in 2017 and is expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Vitrectomy Machines Market

The vitrectomy is a surgical procedure that is carried out by the specialist where the vitreous humor is located in order to provide a better access to the retina. This booklet describes various types of repairs such as the treatment of macular holes, removal of scar tissue, and repair of retinal detachments. In order to help retina hold in position after surgery, gas bubble or silicon oil, saline are injected.

 

Market Dynamics: Vitrectomy Machines Market

Increase in the prevalence of eye diseases in the geriatric population are majorly driving the growth of the vitrectomy machines market. The advancements in the technology is thus playing a significant role in the growth of the market. The growing awareness among the patient population is the adoption of new surgical procedures. However, the high cost of the surgical process, the lack of government support to the non-profitable organizations and poor healthcare policies in developing countries may be hindered by the growth of the vitrectomy machines market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Vitrectomy Machines Market

Vitrectomy machines market is segmented based on product type, applications, and end user.

Based on the product type, the market is segmented into the following:

  • Vitrectomy Machines
  • Vitrectomy Packs
  • Microscopic Illumination Equipment
  • Surgical Instruments
  • Others

Based on the applications, the market is segmented into the following:

  • Retinal detachment
  • Diabetic retinopathy
  • trauma
  • Macular Surgery
  • Pediatric Retinal Disorders
  • Others

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Eye Clinics
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis: Vitrectomy Machines Market

Geographically, Global Vitrectomy Machinery is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America vitrectomy machines market driven by increase in the prevalence of eye diseases. Fraternity in the region is driving the market. Followed by North America is the European and Asia Pacific regions are dominating the market.

 

Competition Assessment: Vitrectomy Machines Market

Some of the players in the global vitrectomy machine market include:

  • IRIDEX Corporation (US)
  • Synergetics, Inc. (US)
  • Bausch & Lomb (US)
  • Optos PLC (UK)
  • Topcon Corporation (Japan)
  • Leica Microsystems GmbH (Germany)
  • Carl Zeiss Meditec AG (Germany)
  • Alcon, Inc. (US)

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments: Vitrectomy Machines Market

  • In August 2017, Bausch + Lomb has launched the Stellaris Elite vision enhancement system for retinal surgery in the US

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/vitrectomy-machines-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firms, which follows a holistic approach to solve the needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and making better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): 1-866-598-1553

Website @ https://www.precisionbusinessinsights.co m

Aktuelle Nachrichten Gesundheit/Medizin Internationales Marketing/Werbung Mode/Lifestyle

Global Wearable Insulin Devices Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Wearable Insulin Devices Market: By Product Type (Patches and Pods), By Age Group (Adults and Pediatrics), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global wearable insulin devices market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Wearable Insulin Devices Market

Wearable insulin devices are the medical devices that helps in controlling or maintaining the blood glucose in the patient’s body. The insulin is the major part in the treatment of diabetes. Insulin is the hormone made by the pancreas which allows the body to use or store the sugar or the glucose from carbohydrates form the food. It allows to maintain the blood sugar level form either getting too high, which would result in hyperglycemia or from getting too low which would result in hypoglycemia.

 

Market Dynamics: Wearable Insulin Devices Market

Increase in the prevalence of diabetes is the major factor anticipated to drive the growth of wearable insulin devices market. Increasing health issues such as obesity and launch technologically advanced devices anticipated to fuel the growth of wearable insulin devices market. The rising awareness among the patient population with regard to advanced treatment options and increasing healthcare expenditure are expected to boost the wearable insulin devices market. The adoption of the self-care diabetes management methods and increasing R&D activities are providing opportunity to the manufacturers to further expansion of the market. However, the high cost of the device may hamper the growth of the wearable insulin devices market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Wearable Insulin Devices Market

Wearable insulin devices market is segmented based on the product type, age group, and distribution channel

Based on the product type, the market is segmented into the following:

  • Patches
  • Pods

Based on the age group, the market is segmented into the following:

  • Adults
  • Pediatrics

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Online Pharmacies
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Wearable Insulin Devices Market

Geographically, global wearable insulin devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America wearable insulin devices market is dominant when compared with that of the other regional markets owing to favorable reimbursement policies and increase in the prevalence of diabetes and obesity. According to the Centers for Disease Control and Prevention (CDC) in the year of 2016, there were 29 million patients in U.S. who are still suffering with diabetes, of which 21.0 million patients were diagnosed and 8.1 million patients are undiagnosed. The increasing awareness about the self-treatment procedures is also enhancing the growth of the wearable insulin devices market. The Asia Pacific is the region expected to offer lucrative growth opportunities owing to large untapped market and availability of large diabetic patient pool in India and China.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Wearable Insulin Devices Market

Some of the players in the global wearable insulin devices market include:

  • Omnipod (U.S)
  • Valeritas, Inc. (U.S)
  • CeQur (Switzerland)
  • Prometheon Pharma (U.S)
  • Sproutel (U.S)
  • MedicSen (Spain)

 

Notable Market Developments: Wearable Insulin Devices Market

  • In January 2018, Valeritas launches V-Go wearable insulin delivery device in Puerto Rico.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/wearable-insulin-devices-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com